NHS Scotland Public Benefit and Privacy Panel (PBPP) – Much Ado about Governance 3 years on

European Public Finances : Much Ado About Nothing ?

In this article, European public finances are analyzed by focusing on the EU budget and the influence of the EU on member states’ taxes and spending. Starting from the economic theory of federalism, the chapter surveys the development of EU revenue, spending and off-budget activities, discusses the redistributive impact of the EU budget on member states, budgetary decision-making procedures and...

The new Medicare drug benefit: much ado about little?

After many years of debate, Congress recently approved a new, voluntary "Medicare Part D" benefit that provides some coverage for prescription drugs. The goal of this coverage is to reduce financial barriers that might prevent beneficiaries from obtaining needed drugs. The degree to which this goal is achieved depends on how well the benefit reaches seniors with previously unmet needs; converse...

Much ado about nothing?

I t all started with the submission of an unsolicited review on idiopathic pulmonary haemosiderosis by IOACHIMESCU et al. [1]. During the review process of this excellent manuscript, the idea evolved to launch a whole series on rare (orphan) interstitial lung disorders in the European Respiratory Journal. Why bother? Well, admittedly, these diseases are rare, but for the affected patient that d...

Much ado about nothing?

Much Ado about Nogo

Three proteins in mature myelin (Nogo, MAG, and OMgp) have been purported to be critical in causing both regenerative failure and minimal sprouting after CNS injury. However, the role of this repulsive trio in vivo has been controversial. Lee et al., in this issue of Neuron, provide evidence that genetically deleting all three major myelin inhibitors either singly or all together does not resul...